Dear Editor,

The results in this work have the potential to influence screening guidelines but all imaging combinations (contrast enhanced magnetic resonance imaging (CEMRI) + digital breast tomosynthesis (DBT), unenhanced magnetic resonance imaging (UMRI) only, or DBT only) should and could have been evaluated with the current data set. These combinations may help determine the reason for a lower false positive (FP) rate in the UMRI + DBT case.

The increased number of false negatives in the UMRI + DBT case is concerning \[[@bib1]\]. While the conclusion states that UMRI + DBT may help reduce false positives (FP) when compared to CEMRI, the increase in false negatives (FN) should not be overlooked. Studies have shown that women are aware of FP and are willing to accept the inconveniences of extra screening if a possible cancer can be found earlier \[[@bib2],[@bib3]\]. Improving specificity, by decreasing false positives, should not be at the cost of sacrificing sensitivity or increasing FN.

It is unlikely that extracting the UMRI images from a full CEMRI is a feasible or practical method of acquiring images. Sparse MRI methods may be a more efficient way of obtaining UMRI and future work may want to consider this imaging method if images are comparable [@bib4], [@bib5].
